Also trades as: MAQAF (OTC) · $vol 0M
ALX.AX ASX
Atlas Arteria Limited
1W: -3.1%
1M: -16.1%
3M: -25.7%
YTD: -19.4%
1Y: -24.6%
3Y: -20.6%
5Y: -17.2%
A$3.74 ($2.60)
-0.05 (-1.32%)
Weekly Expected Move ±4.9%
A$3
A$4
A$4
A$4
A$4
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$160M
+10.3% ▲
5Y CAGR: +8.9%
Gross Profit
$14M
-90.3% ▼
Operating Income
-$8M
+7.4% ▲
Net Income
$260M
-22.7% ▼
EPS (Diluted)
$0.18
-21.7% ▼
EBITDA
$64M
-39.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $101M | $118M | $134M | $145M | $160M |
| YoY Growth | -3.9% | +17.6% | +13.3% | +8.2% | +10.3% |
| Cost of Revenue | $110M | $118M | $118M | $6M | $146M |
| Gross Profit | -$9M | $116K | $16M | $139M | $14M |
| Gross Margin | -9.0% | 0.1% | 12.2% | 95.7% | 8.4% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $16M | $23M | $33M | $35M | $21M |
| Operating Expenses | $16M | $23M | $22M | $147M | $21M |
| Operating Income | -$25M | -$23M | -$5M | -$8M | -$8M |
| Operating Margin | -24.8% | -19.7% | -3.8% | -5.6% | -4.7% |
| Interest Expense | $131M | $91M | $96M | $95M | $97M |
| Income Before Tax | $128M | $244M | $260M | $278M | $190M |
| Tax Expense | -$36M | $3M | $4M | $3M | $8M |
| Net Income | $164M | $267M | $324M | $336M | $260M |
| Net Margin | 162.9% | 225.8% | 241.4% | 231.7% | 162.2% |
| EPS (Diluted) | $0.16 | $0.22 | $0.22 | $0.23 | $0.18 |
| EBITDA | -$12M | $63M | $426M | $106M | $64M |
| Shares Outstanding | 1.45B | 1.45B | 1.45B | 1.45B | 1.45B |